Literature DB >> 5071634

Complement-fixing activity of rheumatoid synovial fluid.

A S Townes, R L Marcus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5071634      PMCID： PMC1005951          DOI： 10.1136/ard.31.5.393

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  27 in total

1.  TOTAL HEMOLYTIC COMPLEMENT (CH50) AND SECOND COMPONENT OF COMPLEMENT (C2 HU) ACTIVITY IN SERUM AND SYNOVIAL FLUID.

Authors:  G FOSTIROPOULOS; K F AUSTEN; K J BLOCH
Journal:  Arthritis Rheum       Date:  1965-04

Review 2.  The role of immune complexes and complement in tissue injury.

Authors:  C G Cochrane
Journal:  J Allergy       Date:  1968-09

3.  Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

4.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

5.  Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases.

Authors:  R Baumal; I Broder
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

6.  Relation of intracytoplasmic inclusions in joint fluid leukocytes to anti-gamma-G globulins.

Authors:  J H Vaughan; R J Jacox; P Noell
Journal:  Arthritis Rheum       Date:  1968-04

7.  Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases.

Authors:  J H Vaughan; E V Barrnett; M V Sobel; R F Jacox
Journal:  Arthritis Rheum       Date:  1968-04

8.  Relation of rheumatoid factor to intracellular inclusions.

Authors:  J H Vaughan; R F Jacox; G Abraham; R Clark
Journal:  Ann N Y Acad Sci       Date:  1969-12-10       Impact factor: 5.691

9.  Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis.

Authors:  S Ruddy; M C Britton; P H Schur; K F Austen
Journal:  Ann N Y Acad Sci       Date:  1969-12-10       Impact factor: 5.691

10.  [Studies on hemolytic complement in certain osteoarticular diseases. Over-all results].

Authors:  A Peltier; F Coste; F Delbarre
Journal:  Presse Med       Date:  1966-06-11       Impact factor: 1.228
View more
  4 in total

1.  Detection of IgG rheumatoid factor by concanavalin A treatment and complement fixation with IgG rheumatoid factor.

Authors:  K Tanimoto; T Moritoh; T Azuma; Y Horiuchi
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

2.  Studies into the occurrence of soluble antigen-antibody complexes in disease. VI. Further characterization of the biological and physical properties of the rheumatoid biologically active factor (RBAF).

Authors:  I Broder; E Tackaberry; M Urowitz; L Russell; R Baumal
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

3.  Enhancement of human lymphocyte transformation by aggregated human gamma globulin.

Authors:  T D Kinsella
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

4.  Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

Authors:  A E Bedwell; C J Elson; S D Carter; P A Dieppe; C W Hutton; R Czudek
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.